학술논문
Time to Next Treatment, Healthcare Resource Utilization, and Healthcare Costs Among Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Following First-Line Ibrutinib
Document Type
Abstract
Author
Source
In Blood 23 November 2021 138 Supplement 1:4016-4016
Subject
Language
ISSN
0006-4971